{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:03:16Z","timestamp":1782846196452,"version":"3.54.5"},"reference-count":46,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Cancer"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Chronic myeloid leukemia (CML) has evolved into a chronic condition as a consequence of effective tyrosine kinase inhibitor (TKI) therapy, leading to an expanding demographic of patients necessitating lifelong monitoring. The use of eHealth solutions has the potential to facilitate sustainable and patient-centered care by enabling remote monitoring and enhancing guideline adherence. The Dutch CMyLife digital care platform incorporates a CML Dashboard intended for health care professionals (HCPs). This dashboard is designed to provide insight into real-world CML care and enable remote monitoring.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aimed to evaluate the feasibility of the CML Dashboard for remote monitoring of CML care, to assess the usefulness of dashboard-derived data, and to identify barriers and facilitators for its implementation in routine clinical practice.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We conducted a multimethods early-stage evaluation, determining the feasibility of the CML Dashboard and its barriers and facilitators. Quantitative data were generated through the CMyLife app and displayed in the CML Dashboard. These data were collected over a 2.5-year period and analyzed descriptively. Concurrently, semistructured interviews were conducted with HCPs treating patients with CML to explore barriers and facilitators for implementation. The analysis of interview transcripts was conducted using framework analysis, using established implementation models.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of the 199 patients who were registered, 177 provided data to the dashboard. The dashboard provided insight into patient characteristics, TKI treatment, BCR::ABL1 values, and monitoring intervals. However, the completeness and reliability of the data were limited, as the majority of the data were manually entered by the patients. The absence of complete data and the presence of inconsistencies in monitoring time points reduced the immediate usability of the dashboard for clinical decision-making and quality monitoring. A total of 8 HCPs participated in the interviews. The facilitators included an enhanced overview of patient data, support for consultation preparation, and the potential for remote monitoring and quality improvement. Key barriers identified were the lack of integration with electronic medical records, the necessity for additional log-in procedures, the limited adoption of the app by patients, and the perception of its added value as being inferior to existing systems.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The prospect of implementing a remote monitoring system for CML care holds promise. Such a system, using a digital dashboard, has the potential to enhance oversight and contribute to the enhancement of quality assurance. Nonetheless, the implementation of automated data exchange with electronic medical records, enhanced data completeness, and the augmentation of integration into clinical workflows are imperative prior to the large-scale implementation and the transition toward home-based CML care.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/76096","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T20:21:50Z","timestamp":1778185310000},"page":"e76096-e76096","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility and Implementation of an eHealth Dashboard for the Remote Monitoring of Dutch Patients With Chronic Myeloid Leukemia: Multimethods Approach"],"prefix":"10.2196","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3904-9509","authenticated-orcid":false,"given":"Lynn","family":"Verweij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9337-1318","authenticated-orcid":false,"given":"Julie E M","family":"Swillens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8249-9285","authenticated-orcid":false,"given":"Sanne J J P M","family":"Metsemakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4799-4981","authenticated-orcid":false,"given":"Yolba","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5066-3779","authenticated-orcid":false,"given":"Esri","family":"Wener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1558-944X","authenticated-orcid":false,"given":"Genevi\u00e8ve I C G","family":"Ector","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7624-7120","authenticated-orcid":false,"given":"Rosella P M G","family":"Hermens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1801-2072","authenticated-orcid":false,"given":"Nicole M A","family":"Blijlevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"10","key":"R1","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1158\/1055-9965.EPI-11-0650","article-title":"Economic burden of cancer in the United States: estimates, projections, and future research","volume":"20","author":"Yabroff","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"R2","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.clinthera.2015.03.022","article-title":"Evaluation of a remote monitoring system for diabetes control","volume":"37","author":"Katalenich","journal-title":"Clin Ther"},{"issue":"11","key":"R3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12170-023-00726-1","article-title":"Remote monitoring in cardiovascular diseases","volume":"17","author":"Pelter","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"23","key":"R4","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","journal-title":"N Engl J Med"},{"issue":"24","key":"R5","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1200\/JCO.2015.66.2866","article-title":"Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population","volume":"34","author":"Bower","journal-title":"J Clin Oncol"},{"issue":"5","key":"R6","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/bjh.17989","article-title":"The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population-based study in the Netherlands, 1989-2018","volume":"196","author":"Maas","journal-title":"Br J Haematol"},{"issue":"6","key":"R7","first-page":"237","volume":"8","author":"Ossenkoppele","journal-title":"Ned Tijdschr Hematol"},{"issue":"2","key":"R8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/10428194.2022.2142055","article-title":"Adherence to quality indicators in chronic myeloid leukemia care: results from a population-based study in the Netherlands","volume":"64","author":"Ector","journal-title":"Leuk Lymphoma"},{"issue":"22","key":"R9","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1182\/blood.V128.22.3079.3079","article-title":"Adherence to chronic myeloid leukemia monitoring and treatment guidelines in Canadian registries","volume":"128","author":"Hillis","journal-title":"Blood"},{"issue":"3","key":"R10","doi-asserted-by":"publisher","first-page":"e398","DOI":"10.1200\/JOP.2014.001099","article-title":"Barriers to physician adherence to evidence-based monitoring guidelines in chronic myelogenous leukemia","volume":"11","author":"Goldberg","journal-title":"J Oncol Pract"},{"issue":"12","key":"R11","doi-asserted-by":"publisher","first-page":"e486","DOI":"10.3324\/haematol.2017.175265","article-title":"Impact of hospital experience on the quality of tyrosine kinase inhibitor response monitoring and consequence for chronic myeloid leukemia patient survival","volume":"102","author":"Geelen","journal-title":"Haematologica"},{"issue":"11","key":"R12","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.3324\/haematol.2017.174953","article-title":"Treatment outcome in a population-based, \u201creal-world\u201d cohort of patients with chronic myeloid leukemia","volume":"102","author":"Geelen","journal-title":"Haematologica"},{"issue":"4","key":"R13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.clml.2012.04.002","article-title":"Adherence to BCR-ABL inhibitors: issues for CML therapy","volume":"12","author":"Jabbour","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2015.08.025","article-title":"To adhere or not to adhere: rates and reasons of medication adherence in hematological cancer patients","volume":"97","author":"Hall","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"R15","doi-asserted-by":"publisher","DOI":"10.2196\/18901","article-title":"Effect of interactive eHealth interventions on improving medication adherence in adults with long-term medication: systematic review","volume":"23","author":"Pouls","journal-title":"J Med Internet Res"},{"issue":"8","key":"R16","doi-asserted-by":"publisher","DOI":"10.2196\/17015","article-title":"Improving patients\u2019 medication adherence and outcomes in nonhospital settings through eHealth: systematic review of randomized controlled trials","volume":"22","author":"Wong","journal-title":"J Med Internet Res"},{"issue":"1","key":"R17","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-09153-9","article-title":"Effectiveness of digital care platform CMyLife for patients with chronic myeloid leukemia: results of a patient-preference trial","volume":"23","author":"Verweij","journal-title":"BMC Health Serv Res"},{"key":"R18","unstructured":"Innovative care for chronic conditions: building blocks for actions. World Health Organization; Oct 31, 2002. URL: https:\/\/www.who.int\/publications\/i\/item\/innovative-care-for-chronic-conditions-building-blocks-for-actions [Accessed 16-04-2026]"},{"issue":"5","key":"R19","doi-asserted-by":"publisher","DOI":"10.2196\/15895","article-title":"The development of a web-based, patient-centered intervention for patients with chronic myeloid leukemia (CMyLife): design thinking development approach","volume":"22","author":"Ector","journal-title":"J Med Internet Res"},{"issue":"6","key":"R20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated Criteria for Reporting Qualitative Research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","journal-title":"Int J Qual Health Care"},{"key":"R21","unstructured":"Chronic myeloid leukemia. Nederlandse Vereniging voor Hematologie. Dec 6, 2023. URL: https:\/\/publicatie.hematologienederland.nl\/richtlijnen\/chronische-myeloide-leukemie-2 [Accessed 16-04-2026]"},{"key":"R22","unstructured":"CMyLife. URL: www.cmylife.nl [Accessed 16-04-2026]"},{"key":"R23","unstructured":"cmyCML. URL: https:\/\/www.cmycml.nl [Accessed 16-04-2026]"},{"key":"R24","unstructured":"PGO.nl. URL: www.pgo.nl\/partners [Accessed 16-04-2026]"},{"key":"R25","unstructured":"MedMij. URL: www.medmij.nl [Accessed 16-04-2026]"},{"key":"R26","unstructured":"Patients Know Best. URL: https:\/\/www.patientsknowbest.nl [Accessed 16-04-2026]"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.2196\/45259","article-title":"Improvement, implementation, and evaluation of the CMyLife digital care platform: participatory action research approach","volume":"25","author":"Verweij","journal-title":"J Med Internet Res"},{"issue":"4","key":"R28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/1937586715614171","article-title":"Qualitative descriptive methods in health science research","volume":"9","author":"Colorafi","journal-title":"HERD Health Environ Res Des J"},{"issue":"5","key":"R29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/1744987119880234","article-title":"An overview of the qualitative descriptive design within nursing research","volume":"25","author":"Doyle","journal-title":"J Res Nurs"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1748-5908-8-35","article-title":"A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice","volume":"8","author":"Flottorp","journal-title":"Implement Sci"},{"issue":"S6","key":"R31","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.5694\/j.1326-5377.2004.tb05948.x","article-title":"What drives change? Barriers to and incentives for achieving evidence-based practice","volume":"180","author":"Grol","journal-title":"Med J Aust"},{"issue":"20","key":"R32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13205116","article-title":"Which tyrosine kinase inhibitors should be selected as the first-line treatment for chronic myelogenous leukemia in chronic phase?","volume":"13","author":"Ono","journal-title":"Cancers (Basel)"},{"issue":"Suppl 1","key":"R33","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0145-2126(17)30549-0","article-title":"Speaker presentations","volume":"61","author":"Saglio","journal-title":"Leukemia Res"},{"issue":"1","key":"R34","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01309-0","article-title":"A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase","volume":"15","author":"Garc\u00eda-Guti\u00e9rrez","journal-title":"J Hematol Oncol"},{"issue":"5","key":"R35","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/s41375-022-01522-3","article-title":"Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia","volume":"36","author":"Baccarani","journal-title":"Leukemia"},{"issue":"26","key":"R36","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMp1011024","article-title":"What is value in health care?","volume":"363","author":"Porter","journal-title":"N Engl J Med"},{"issue":"10","key":"R37","doi-asserted-by":"publisher","first-page":"e849","DOI":"10.1016\/S2352-3026(23)00173-4","article-title":"Measuring chronic myeloid leukaemia TKI-related toxic effects in the real world: a systematic review and critical assessment of content validity of patient-reported outcome measures","volume":"10","author":"Smit","journal-title":"Lancet Haematol"},{"key":"R38","unstructured":"Nationale strategie voor het gezondheidsinformatiestelsel. Ministry of Health, Welfare and Sport, The Netherlands; Oct 31, 2024. URL: https:\/\/www.rijksoverheid.nl\/documenten\/publicaties\/2024\/10\/31\/nationale-strategie [Accessed 16-04-2026]"},{"issue":"4","key":"R39","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2471\/BLT.20.253955","article-title":"Towards a global strategy on digital health","volume":"98","author":"Mariano","journal-title":"Bull World Health Organ"},{"key":"R40","unstructured":"Kapoor M . Top real world evidence (RWE) platforms. Mahalo Digital Ventures. Mar 20, 2025. URL: https:\/\/www.mahalo.health\/insights\/top-real-world-evidence-rwe-platforms [Accessed 16-04-2026]"},{"issue":"1","key":"R41","doi-asserted-by":"publisher","DOI":"10.1186\/s12912-022-00993-0","article-title":"A mHealth-based nursing model for assessing the health outcomes of the discharged patients with nasopharyngeal carcinoma: a pilot RCT","volume":"21","author":"Liao","journal-title":"BMC Nurs"},{"key":"R42","unstructured":"UZI-register. Ministry of Health, Welfare and Sport, The Netherlands. URL: https:\/\/www.uziregister.nl [Accessed 16-04-2026]"},{"key":"R43","unstructured":"Digital transformation. NHS England. URL: https:\/\/www.england.nhs.uk\/digitaltechnology [Accessed 06-04-2026]"},{"key":"R44","unstructured":"Balla D Belani H Berdun J et al. Building sustainable digital health services in Europe: lessons learned from the COVID-19 pandemic. CroRIS; 2020. URL: https:\/\/www.croris.hr\/crosbi\/publikacija\/rad-ostalo\/789805 [Accessed 30-04-2026]"},{"key":"R45","unstructured":"A cancer plan for Europe. European Commission. May 27, 2025. URL: https:\/\/commission.europa.eu\/topics\/public-health\/european-health-union\/cancer-plan-europe_en [Accessed 16-04-2026]"},{"key":"R46","unstructured":"Integraal Zorgakkoord: \u2018Samen werken aan gezonde zorg\u2019 [in Dutch]. Ministry of Health, Welfare and Sport, The Netherlands; Sep 16, 2022. URL: https:\/\/www.rijksoverheid.nl\/documenten\/rapporten\/2022\/09\/16\/integraal-zorgakkoord-samen-werken-aan-gezonde-zorg [Accessed 16-04-2026]"}],"container-title":["JMIR Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cancer.jmir.org\/2026\/1\/e76096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:07:31Z","timestamp":1782842851000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancer.jmir.org\/2026\/1\/e76096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":46,"URL":"https:\/\/doi.org\/10.2196\/76096","relation":{},"ISSN":["2369-1999"],"issn-type":[{"value":"2369-1999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"article-number":"v12i10e76096"}}